Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
89.4 GBX | -0.67% | -2.83% | +3.59% |
05-07 | AstraZeneca target raised; Antofagasta lowered | AN |
04-17 | De La Rue says yearly profit to be in line with expectations | AN |
Sales 2024 * | 319M 401M 31.89B | Sales 2025 * | 354M 445M 35.43B | Capitalization | 176M 221M 17.63B |
---|---|---|---|---|---|
Net income 2024 * | -3M -3.77M -300M | Net income 2025 * | 11M 13.82M 1.1B | EV / Sales 2024 * | 0.86 x |
Net Debt 2024 * | 99.23M 125M 9.92B | Net Debt 2025 * | 92.42M 116M 9.24B | EV / Sales 2025 * | 0.76 x |
P/E ratio 2024 * |
-44.6
x | P/E ratio 2025 * |
15.5
x | Employees | 1,841 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.73% |
Latest transcript on De La Rue plc
1 day | -0.67% | ||
1 week | -2.83% | ||
Current month | -4.89% | ||
1 month | +12.88% | ||
3 months | +0.90% | ||
6 months | +56.84% | ||
Current year | +3.59% |
Managers | Title | Age | Since |
---|---|---|---|
Clive Vacher
CEO | Chief Executive Officer | - | 06/10/19 |
Dean Moore
DFI | Director of Finance/CFO | 66 | 25/06/23 |
Ruth Euling
BRD | Director/Board Member | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Moore
DFI | Director of Finance/CFO | 66 | 25/06/23 |
Nicholas Bray
BRD | Director/Board Member | 59 | 20/07/16 |
Brian Small
BRD | Director/Board Member | 67 | 07/09/23 |
Date | Price | Change | Volume |
---|---|---|---|
13/05/24 | 89.4 | -0.67% | 558 406 |
10/05/24 | 90 | +0.67% | 250,118 |
09/05/24 | 89.4 | 0.00% | 50,012 |
08/05/24 | 89.4 | -2.83% | 674,939 |
07/05/24 | 92 | -0.65% | 122,459 |
Delayed Quote London S.E., May 13, 2024 at 03:30 pm
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.59% | 221M | |
-6.35% | 7.59B | |
+10.26% | 7.14B | |
+8.52% | 2.22B | |
+180.00% | 1.21B | |
-38.99% | 1.16B | |
+6.43% | 1B | |
-13.78% | 913M | |
-6.32% | 623M | |
-6.18% | 531M |
- Stock Market
- Equities
- DLAR Stock